Jiao Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiao Liang has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Hongqi Dai
Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Nanjing Forestry University, Nanjing, 210037, China
2 shared publications - Huiyang Bian
Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, International Innovation Center for Forest Chemicals and Materials, Nanjing Forestry University, Nanjing, China
2 shared publications - Bin Zhang
Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngology, Shenzhen Institute of Translational Medicine
1 shared publication - Guangyu Zhang
College of Traditional Chinese Medicine, Chongqing Three Gorges Medical College
1 shared publication - Hailong Yu
Department of Orthopedics, General Hospital of Northern Theater Command, Shenyang, China
1 shared publication - Hong Wang
State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
1 shared publication
Latest Publications
- 12 February 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (6) , 3513-3526
Results of postoperative voice therapy for vocal cord polyps: systematic review and meta-analysis
Purpose The recovery of voice quality after vocal cord polyp surgery is a key concern for both patients and physicians. Voice therapy plays a significant role in the conservative treatment of vocal cord polyps. In this study, we aimed to evaluate the effect of postoperative voice therapy on outcomes in patients with vocal cord polyps. Methods According to PRISMA guidelines, we conducted a systematic search for RCTs of postoperative voice therapy for vocal cord polyps published before January 24, 2025, in nine databases. Results Nine RCTs involving 730 patients were included. Postoperative voice therapy significantly reduced VHI (MD = -9.66, 95%CI [-15.80, -3.53], P = 0.002). Additionally, it improved jitter (SMD = -1.16, 95% CI [-1.70, -0.63], P < 0.0001), shimmer (SMD = -1.18, 95% CI [-1.74, -0.63], P < 0.001), and DSI (SMD = 1.53, 95% CI [0.56, 2.49], P = 0.002), and prolonged MPT (SMD = 0.65, 95% CI [0.27, 1.03], P = 0.0008). However, considerable heterogeneity was observed across outcomes including VHI, jitter, shimmer, and DSI, and the overall sample size remains modest. Conclusion Postoperative voice therapy demonstrates efficacy in mitigating VHI, jitter, shimmer, and DSI scores, as well as extending MPT in patients with vocal cord polyps. However, these findings must be interpreted with caution due to the significant heterogeneity among the included studies, potential biases, and limited sample sizes. Future high-quality RCTs with larger sample sizes, standardized therapy protocols, and longer follow-up periods are needed to confirm these.
- 12 February 2026
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 283 (6) , 3513-3526
Results of postoperative voice therapy for vocal cord polyps: systematic review and meta-analysis
Purpose The recovery of voice quality after vocal cord polyp surgery is a key concern for both patients and physicians. Voice therapy plays a significant role in the conservative treatment of vocal cord polyps. In this study, we aimed to evaluate the effect of postoperative voice therapy on outcomes in patients with vocal cord polyps. Methods According to PRISMA guidelines, we conducted a systematic search for RCTs of postoperative voice therapy for vocal cord polyps published before January 24, 2025, in nine databases. Results Nine RCTs involving 730 patients were included. Postoperative voice therapy significantly reduced VHI (MD = -9.66, 95%CI [-15.80, -3.53], P = 0.002). Additionally, it improved jitter (SMD = -1.16, 95% CI [-1.70, -0.63], P < 0.0001), shimmer (SMD = -1.18, 95% CI [-1.74, -0.63], P < 0.001), and DSI (SMD = 1.53, 95% CI [0.56, 2.49], P = 0.002), and prolonged MPT (SMD = 0.65, 95% CI [0.27, 1.03], P = 0.0008). However, considerable heterogeneity was observed across outcomes including VHI, jitter, shimmer, and DSI, and the overall sample size remains modest. Conclusion Postoperative voice therapy demonstrates efficacy in mitigating VHI, jitter, shimmer, and DSI scores, as well as extending MPT in patients with vocal cord polyps. However, these findings must be interpreted with caution due to the significant heterogeneity among the included studies, potential biases, and limited sample sizes. Future high-quality RCTs with larger sample sizes, standardized therapy protocols, and longer follow-up periods are needed to confirm these.
- Open Access
- 24 November 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1)
Bushen Huatan formula alleviates polycystic ovary syndrome in rats by activating the PI3K/Akt pathway to inhibit GSDMD-mediated pyroptosis and mitochondrial damage
Previous studies suggest that the traditional Chinese medicinal formula Bushen Huatan Fang (BSHT) possesses the capacity to modulate hormonal levels in patients with endocrine and metabolic disorders, indicating its potential clinical utility. This study aims to elucidate the specific mechanisms through which BSHT exerts therapeutic effects in a rat model of polycystic ovary syndrome (PCOS). A PCOS model was established in female Sprague-Dawley rats using a high-fat diet and letrozole. Rats were randomly assigned to control, model, positive control (metformin), and BSHT low dose (BSHT-L), medium dose (BSHT-M), and high dose (BSHT-H) groups, with interventions administered for 31 days. Endocrine markers (follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), anti-Müllerian hormone (AMH), insulin resistance (fasting blood glucose (FBG), fasting insulin (INS), homeostasis model assessment of insulin resistance (HOMA-IR)), and ovarian function were assessed by enzyme-linked immunosorbent assay (ELISA), histopathology, and immunohistochemistry. Inflammatory cytokines (interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α)), lactate dehydrogenase (LDH), mitochondrial function (reactive oxygen species (ROS), mitochondrial membrane potential (MMP), ATPase activity), and pyroptosis markers (generating its GSDMD-N, cleaved caspase-1, IL-1β) were measured by Western blot. Network pharmacology predicted BSHT’s active compounds and targets, and PI3K/Akt pathway modulation was evaluated through protein expression analysis. These methods were used to investigate BSHT’s effects on inflammation, mitochondrial dysfunction, and cellular damage in PCOS. BSHT effectively ameliorated metabolic, endocrine, and ovarian abnormalities in PCOS rats. It controlled weight gain, reversed endocrine dysfunction (FSH, LH, E2, LH/FSH), and improved ovarian morphology, including increased corpora lutea and reduced cystic follicles. BSHT also improved insulin resistance, as indicated by decreased FBG, FINS, and HOMA-IR levels, and upregulated GLUT4 expression. It restored ovarian reserve, reduced inflammatory markers (IL-1β, IL-6, TNF-α), and improved mitochondrial function by enhancing ATP activity and reducing ROS levels. Furthermore, BSHT activated the PI3K/Akt pathway, significantly reducing pyroptosis and mitochondrial damage, with effects further enhanced by LY294002. This study shows that BSHT dose-dependently activates the PI3K/Akt pathway, inhibits GSDMD-mediated pyroptosis, and improves mitochondrial dysfunction in PCOS. Its regulation of inflammation, oxidative stress, metabolism, and ovarian function suggests a promising multi-target therapeutic strategy and provides insights for future clinical applications.
- 24 November 2025
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1)
Open AccessBushen Huatan formula alleviates polycystic ovary syndrome in rats by activating the PI3K/Akt pathway to inhibit GSDMD-mediated pyroptosis and mitochondrial damage
Previous studies suggest that the traditional Chinese medicinal formula Bushen Huatan Fang (BSHT) possesses the capacity to modulate hormonal levels in patients with endocrine and metabolic disorders, indicating its potential clinical utility. This study aims to elucidate the specific mechanisms through which BSHT exerts therapeutic effects in a rat model of polycystic ovary syndrome (PCOS). A PCOS model was established in female Sprague-Dawley rats using a high-fat diet and letrozole. Rats were randomly assigned to control, model, positive control (metformin), and BSHT low dose (BSHT-L), medium dose (BSHT-M), and high dose (BSHT-H) groups, with interventions administered for 31 days. Endocrine markers (follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), anti-Müllerian hormone (AMH), insulin resistance (fasting blood glucose (FBG), fasting insulin (INS), homeostasis model assessment of insulin resistance (HOMA-IR)), and ovarian function were assessed by enzyme-linked immunosorbent assay (ELISA), histopathology, and immunohistochemistry. Inflammatory cytokines (interleukin-1 beta (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α)), lactate dehydrogenase (LDH), mitochondrial function (reactive oxygen species (ROS), mitochondrial membrane potential (MMP), ATPase activity), and pyroptosis markers (generating its GSDMD-N, cleaved caspase-1, IL-1β) were measured by Western blot. Network pharmacology predicted BSHT’s active compounds and targets, and PI3K/Akt pathway modulation was evaluated through protein expression analysis. These methods were used to investigate BSHT’s effects on inflammation, mitochondrial dysfunction, and cellular damage in PCOS. BSHT effectively ameliorated metabolic, endocrine, and ovarian abnormalities in PCOS rats. It controlled weight gain, reversed endocrine dysfunction (FSH, LH, E2, LH/FSH), and improved ovarian morphology, including increased corpora lutea and reduced cystic follicles. BSHT also improved insulin resistance, as indicated by decreased FBG, FINS, and HOMA-IR levels, and upregulated GLUT4 expression. It restored ovarian reserve, reduced inflammatory markers (IL-1β, IL-6, TNF-α), and improved mitochondrial function by enhancing ATP activity and reducing ROS levels. Furthermore, BSHT activated the PI3K/Akt pathway, significantly reducing pyroptosis and mitochondrial damage, with effects further enhanced by LY294002. This study shows that BSHT dose-dependently activates the PI3K/Akt pathway, inhibits GSDMD-mediated pyroptosis, and improves mitochondrial dysfunction in PCOS. Its regulation of inflammation, oxidative stress, metabolism, and ovarian function suggests a promising multi-target therapeutic strategy and provides insights for future clinical applications.
- 12 September 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 40 (7) , 819-829
Injectable hydrogels loaded with EGCG /KGN for the treatment of osteoarthritis
Osteoarthritis is confronted with a multifaceted pathological microenvironment, and the implementation of palliative pharmacological strategies facilitates the continued progression of osteoarthritis. In this study, a dynamic hydrogel composed of oxidized hyaluronic acid and gelatin was devised for encapsulating and dispensing EGCG to combat inflammation and oxidative stress in the initial phase, stimulating the differentiation of BMSCs to preserve the metabolic equilibrium of the extracellular matrix through the gradual release of KGN-loaded PLGA microspheres. Subsequently, accomplished adhesion and in-situ delivery were achieved through minimally invasive injection into the joint cavity. These hydrogels possess excellent shear-thinning properties and biocompatibility. The design of double-loaded hydrogel is capable of eradicating intracellular reactive oxygen species while fostering cartilage differentiation via controlled release of EGCG and KGN. A double-loaded injectable hydrogel may provide a new idea for early minimally invasive treatment of osteoarthritis.
- 12 September 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 40 (7) , 819-829
Injectable hydrogels loaded with EGCG /KGN for the treatment of osteoarthritis
Osteoarthritis is confronted with a multifaceted pathological microenvironment, and the implementation of palliative pharmacological strategies facilitates the continued progression of osteoarthritis. In this study, a dynamic hydrogel composed of oxidized hyaluronic acid and gelatin was devised for encapsulating and dispensing EGCG to combat inflammation and oxidative stress in the initial phase, stimulating the differentiation of BMSCs to preserve the metabolic equilibrium of the extracellular matrix through the gradual release of KGN-loaded PLGA microspheres. Subsequently, accomplished adhesion and in-situ delivery were achieved through minimally invasive injection into the joint cavity. These hydrogels possess excellent shear-thinning properties and biocompatibility. The design of double-loaded hydrogel is capable of eradicating intracellular reactive oxygen species while fostering cartilage differentiation via controlled release of EGCG and KGN. A double-loaded injectable hydrogel may provide a new idea for early minimally invasive treatment of osteoarthritis.
- Open Access
- 14 February 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (7) , e41539
Safety and efficacy of carbon dioxide laser therapy for vocal cord leukoplakia: A systematic review and meta-analysis
Background: Vocal cord leukoplakia is a precancerous lesion for which early surgical intervention following ineffective conservative treatment is the predominant approach. Carbon dioxide (CO2) laser treatment is a novel, minimally invasive therapy. However, there is insufficient evidence to suggest that CO2 laser treatment is superior to conventional surgical methods in terms of efficacy and safety. Therefore, this meta-analysis aimed to evaluate the efficacy and safety of CO2 laser treatment vs conventional surgical treatment for vocal cord leukoplakia. Methods: A literature search was conducted using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across 8 databases. Studies on the use of carbon dioxide laser therapy for vocal cord leukoplakia were included in the review. Two researchers conducted a systematic search for randomized controlled trials in PubMed, Embase, Cochrane, Web of Science, China National Knowledge Infrastructure, Wanfang, Chinese Science and Technology Periodical Database, and Chinese Biomedical Literature databases. Meta-analysis was performed using Stata 18.0, and RevMan 5.2 software. Results: The findings indicated that Compared with conventional surgery, CO2 laser surgery significantly reduced the recurrence rate of vocal cord leukoplakia (odds ratio [OR] = 0.25, 95% confidence interval, CI [0.12, 0.51]). CO2 laser surgery significantly improved the cure rate of vocal cord leukoplakia (OR = 3.07, 95% CI [1.17, 8.09]). Voice quality following CO2 laser surgery was significantly superior to that following conventional surgery, particularly in terms of fundamental frequency disturbance (standardized mean difference [SMD] = −0.8, 95% CI [−1.25, −0.34]) and amplitude disturbance (SMD = −0.52, 95% CI [−0.95, −0.09]). The CO2 laser group exhibited a lower incidence of postoperative adverse reactions (OR = 0.32, 95% CI [0.03, 3.19]); however, this difference was not statistically significant. Conclusion: The results of this meta-analysis suggest that CO2 laser surgery can reduce the recurrence rate of vocal cord leukoplakia, improve the cure rate, and enhance voice quality. Therefore, CO2 laser surgery is recommended as a minimally invasive surgical approach for vocal cord leukoplakia.
- 14 February 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (7) , e41539
Open AccessSafety and efficacy of carbon dioxide laser therapy for vocal cord leukoplakia: A systematic review and meta-analysis
Background: Vocal cord leukoplakia is a precancerous lesion for which early surgical intervention following ineffective conservative treatment is the predominant approach. Carbon dioxide (CO2) laser treatment is a novel, minimally invasive therapy. However, there is insufficient evidence to suggest that CO2 laser treatment is superior to conventional surgical methods in terms of efficacy and safety. Therefore, this meta-analysis aimed to evaluate the efficacy and safety of CO2 laser treatment vs conventional surgical treatment for vocal cord leukoplakia. Methods: A literature search was conducted using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across 8 databases. Studies on the use of carbon dioxide laser therapy for vocal cord leukoplakia were included in the review. Two researchers conducted a systematic search for randomized controlled trials in PubMed, Embase, Cochrane, Web of Science, China National Knowledge Infrastructure, Wanfang, Chinese Science and Technology Periodical Database, and Chinese Biomedical Literature databases. Meta-analysis was performed using Stata 18.0, and RevMan 5.2 software. Results: The findings indicated that Compared with conventional surgery, CO2 laser surgery significantly reduced the recurrence rate of vocal cord leukoplakia (odds ratio [OR] = 0.25, 95% confidence interval, CI [0.12, 0.51]). CO2 laser surgery significantly improved the cure rate of vocal cord leukoplakia (OR = 3.07, 95% CI [1.17, 8.09]). Voice quality following CO2 laser surgery was significantly superior to that following conventional surgery, particularly in terms of fundamental frequency disturbance (standardized mean difference [SMD] = −0.8, 95% CI [−1.25, −0.34]) and amplitude disturbance (SMD = −0.52, 95% CI [−0.95, −0.09]). The CO2 laser group exhibited a lower incidence of postoperative adverse reactions (OR = 0.32, 95% CI [0.03, 3.19]); however, this difference was not statistically significant. Conclusion: The results of this meta-analysis suggest that CO2 laser surgery can reduce the recurrence rate of vocal cord leukoplakia, improve the cure rate, and enhance voice quality. Therefore, CO2 laser surgery is recommended as a minimally invasive surgical approach for vocal cord leukoplakia.
- 4 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Algorithm for Underwater Weak Light Signal Recovery Based on Time Thresholding
Under long-distance underwater wireless optical communication, a signal recovery algorithm based on time threshold judgment is proposed to receive weak optical signals at the nano-watt level, and the algorithm is simulated by using Field Programmable Gate Array(FPGA). Finally, an experimental platform is built to conduct a performance test, which shows that the use of the algorithm reduces the communication bit error rate(BER) by 17.6 dB under the same test environment. It is significant for the communication quality of underwater wireless optical communication.
- 4 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Algorithm for Underwater Weak Light Signal Recovery Based on Time Thresholding
Under long-distance underwater wireless optical communication, a signal recovery algorithm based on time threshold judgment is proposed to receive weak optical signals at the nano-watt level, and the algorithm is simulated by using Field Programmable Gate Array(FPGA). Finally, an experimental platform is built to conduct a performance test, which shows that the use of the algorithm reduces the communication bit error rate(BER) by 17.6 dB under the same test environment. It is significant for the communication quality of underwater wireless optical communication.
- Open Access
- 25 April 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (17) , e33600
Dekyphosis operation combined with limited osteotomy to treat the symptomatic adult tethered cord syndrome with complicated malformations: A case report
Rationale: Tethered cord syndrome (TCS) represents a spectrum of neurological symptoms that are caused by constant or intermittent axial traction of the terminal cone of the spinal cord due to abnormal positioning. It is uncommon for abnormal structures of TCS to be accompanied by split cord malformation, thoracic spinal stenosis, and other spinal cord diseases. Patient concerns: A 45-year-old male patient visited our hospital due to severe lower back pain, extensive left lower limb muscle weakness, and intermittent claudication. Diagnoses: TCS combined with stenosis of the thoracic canal, split cord malformation, and kyphosis deformity. Interventions: The patient underwent Dekyphosis operation combined with limited osteotomy symptoms. Outcomes: The patient felt the right lower limb improved after surgery. At 4-month follow-up, a radiological examination showed adequate decompression of the spinal cord and a good internal fixation position. Overall, the patient’s clinical symptoms significantly improved. Conclusion: This is a rare case of TCS combined with thoracic disc herniation and bony mediastinum. A more conservative invasive surgical approach was elected and markedly improved the patient’s symptoms. Additional clinical cases are needed to confirm the stability and feasibility of this surgical approach.
- 25 April 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (17) , e33600
Open AccessDekyphosis operation combined with limited osteotomy to treat the symptomatic adult tethered cord syndrome with complicated malformations: A case report
Rationale: Tethered cord syndrome (TCS) represents a spectrum of neurological symptoms that are caused by constant or intermittent axial traction of the terminal cone of the spinal cord due to abnormal positioning. It is uncommon for abnormal structures of TCS to be accompanied by split cord malformation, thoracic spinal stenosis, and other spinal cord diseases. Patient concerns: A 45-year-old male patient visited our hospital due to severe lower back pain, extensive left lower limb muscle weakness, and intermittent claudication. Diagnoses: TCS combined with stenosis of the thoracic canal, split cord malformation, and kyphosis deformity. Interventions: The patient underwent Dekyphosis operation combined with limited osteotomy symptoms. Outcomes: The patient felt the right lower limb improved after surgery. At 4-month follow-up, a radiological examination showed adequate decompression of the spinal cord and a good internal fixation position. Overall, the patient’s clinical symptoms significantly improved. Conclusion: This is a rare case of TCS combined with thoracic disc herniation and bony mediastinum. A more conservative invasive surgical approach was elected and markedly improved the patient’s symptoms. Additional clinical cases are needed to confirm the stability and feasibility of this surgical approach.
- 2 February 2022
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 29 (26) , 39702-39711
Phosphomolybdic acid-catalyzed oxidation of waste starch: a new strategy for handling the OCC pulping wastewater
When old corrugated cardboard (OCC) is returned to the paper mill for repulping and reuse, the starch, which is added to the paper surface as a reinforcement agent, is dissolved into the pulping wastewater. Most of the OCC pulping wastewater is recycled to save precious water resources; however, during the water recycling process, the accumulation of dissolved starch stimulates microbial reproduction, which causes poor water quality and putrid odor. This problem seriously affects the stability of the papermaking process and product quality. In this study, phosphomolybdic acid (H3PMo12O40, abbreviated as PMo12) was utilized to catalyze the waste starch present in papermaking wastewater to monosaccharides, realizing the resource utilization of waste starch. The results showed that the optimized yield of total reducing sugar (78.68 wt%) and glycolic acid (12.83 wt%) was achieved at 145 °C with 30 wt% PMo12 at pH 2, which is equivalent to 91.51 wt% starch recovered from wastewater for resource utilization. In addition, the regeneration of the reduced PMo12 was realized by applying a potential of 1 V for 2 h. Overall, this study has theoretical significance and potential application value for resource utilization of waste starch in OCC pulping process and cleaner management of OCC waste paper.
- 2 February 2022
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 29 (26) , 39702-39711
Phosphomolybdic acid-catalyzed oxidation of waste starch: a new strategy for handling the OCC pulping wastewater
When old corrugated cardboard (OCC) is returned to the paper mill for repulping and reuse, the starch, which is added to the paper surface as a reinforcement agent, is dissolved into the pulping wastewater. Most of the OCC pulping wastewater is recycled to save precious water resources; however, during the water recycling process, the accumulation of dissolved starch stimulates microbial reproduction, which causes poor water quality and putrid odor. This problem seriously affects the stability of the papermaking process and product quality. In this study, phosphomolybdic acid (H3PMo12O40, abbreviated as PMo12) was utilized to catalyze the waste starch present in papermaking wastewater to monosaccharides, realizing the resource utilization of waste starch. The results showed that the optimized yield of total reducing sugar (78.68 wt%) and glycolic acid (12.83 wt%) was achieved at 145 °C with 30 wt% PMo12 at pH 2, which is equivalent to 91.51 wt% starch recovered from wastewater for resource utilization. In addition, the regeneration of the reduced PMo12 was realized by applying a potential of 1 V for 2 h. Overall, this study has theoretical significance and potential application value for resource utilization of waste starch in OCC pulping process and cleaner management of OCC waste paper.
- 26 November 2018
- Published by Springer Nature in Fibers and Polymers
- Vol. 19 (11) , 2237-2244
Highly Dispersible Cellulose Nanofibrils Produced via Mechanical Pretreatment and TEMPO-mediated Oxidation
- 26 November 2018
- Published by Springer Nature in Fibers and Polymers
- Vol. 19 (11) , 2237-2244
Highly Dispersible Cellulose Nanofibrils Produced via Mechanical Pretreatment and TEMPO-mediated Oxidation